Sandbox: HCL therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
==Overview==
==Overview==
==Medical Therapy==
==Medical Therapy==
* The mainstay of therapy for hairy cell leukemia patients is chemotherapy.
* Asymptomatic hairy cell leukemia patients, with no indications for therapy, may be managed by observation and close follow-up.
* Indications to initiate medical therapy among patients with hairy cell leukemia include:
* Indications to initiate medical therapy among patients with hairy cell leukemia include:
:* The presence of systemic symptoms such as fever, night sweats, and significant weight loss
:* The presence of systemic symptoms such as fever, night sweats, and significant weight loss
Line 8: Line 10:
:* Platelets count lower than 100,000/mcl
:* Platelets count lower than 100,000/mcl
:* Absolute neutrophil count lower than 1000/mcl
:* Absolute neutrophil count lower than 1000/mcl
* Pharmacological agents used for the treatment of hairy cell leukemia patients include:
* Pharmacological agents used for the treatment of hairy cell leukemia patients include:
:* [[Cladribine]]  
:* [[Cladribine]]  

Revision as of 23:15, 29 October 2015

Overview

Medical Therapy

  • The mainstay of therapy for hairy cell leukemia patients is chemotherapy.
  • Asymptomatic hairy cell leukemia patients, with no indications for therapy, may be managed by observation and close follow-up.
  • Indications to initiate medical therapy among patients with hairy cell leukemia include:
  • The presence of systemic symptoms such as fever, night sweats, and significant weight loss
  • The presence of subcostal abdominal discomfort due splenic distension
  • Positive history of recurrent infections.
  • Hemoglobin concentration lower than 12 g/dl
  • Platelets count lower than 100,000/mcl
  • Absolute neutrophil count lower than 1000/mcl
  • Pharmacological agents used for the treatment of hairy cell leukemia patients include: